Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy

Authors

Anthony O. Odibo, Washington University School of Medicine in St. Louis
Harish M. Sehdev, Pennsylvania Hospital, Philadelphia
Laura Sproat, University of Pennsylvania Medical Center, Philadelphia
Claudia Parra, University of Pennsylvania Medical Center, Philadelphia
Linda Odibo, University of Pennsylvania Medical Center, Philadelphia
Linda Dunn, Chestnut Hill Hospital, Philadelphia
George A. Macones, Washington University School of Medicine in St. LouisFollow

Journal

Journal of Ultrasound in Medicine

Publication Date

2006

Volume

25

Issue

4

Inclusive Pages

437–441

Document Type

Open Access Publication

Rights and Permissions

Odibo, A. O., Sehdev, H. M., Sproat, L., Parra, C., Odibo, L., Dunn, L., & Macones, G. A. (2006). Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy. Journal of Ultrasound in Medicine, 25(4), 437-441. Permission to post granted by American Institute of Ultrasound in Medicine. http:/www.jultrasoundmed.org/

Recommended Citation

Odibo, Anthony O.; Sehdev, Harish M.; Sproat, Laura; Parra, Claudia; Odibo, Linda; Dunn, Linda; and Macones, George A., "Evaluating the efficiency of using second-trimester nasal bone hypoplasia as a single or a combined marker for fetal aneuploidy." Journal of Ultrasound in Medicine. 25, 4. 437–441. (2006).
https://digitalcommons.wustl.edu/open_access_pubs/1833